Reviva Pharmaceuticals Holdings, Inc. (RVPH) NASDAQ
0.93
+0.0185(+2.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.93
+0.0185(+2.03%)
Currency In USD
| Market Cap | 20.24M |
| Enterprise Value | -14.03T |
| P/E Ratio | -0 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.25 |
| Return On Equity | -9.19 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.2T |
| Net Income | -19.86T |
| Diluted EPS | -5.48 |
| Total Cash | 14.44T |
| Total Cash/Share | 3.98M |
| Total Debt | 406.88B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.08 |
| Book Value Per Share | 2.38M |
| 52-Week Change | -93.88 |
| 52-Week High | 23.2 |
| 52-Week Low | 0.59 |
| Moving Average 50 Days | 2.59 |
| Moving Average 200 Days | 7.62 |
| Average Volume | 542,663 |
| Shares Outstanding | 3.41M |
| % Held by Institutions | 15.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 09, 2026 |